NCT02316015

Brief Summary

The aim of this study is to investigate if a standardized nutritional intervention with a protein and energy enriched milk could help overcome the catabolic state in children hospitalized with a bronchiolitis and thus creating a better nutritional state during hospitalization and at outpatient follow-up. The investigators also want to assess the clinical repercussion on the number of hospitalization days, the duration of oxygen support and the quality of life at ouptatient follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

December 5, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 12, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 16, 2015

Status Verified

June 1, 2015

Enrollment Period

1.2 years

First QC Date

December 5, 2014

Last Update Submit

June 15, 2015

Conditions

Keywords

Child, HospitalizedNutritional status

Outcome Measures

Primary Outcomes (1)

  • Evolution of nutritional status during hospitalization

    The change in followong parameters will be assessed: * Change in weight for age z-score * Change in mid upper arm circumference z-score * Change in triceps skin fold (mm)

    Hospital stay (mean 5 days)

Secondary Outcomes (1)

  • Evolution of nutritional status at outpatient follow-up

    1 week after discharge

Other Outcomes (6)

  • The Quality of life at outpatient follow-up

    1 week after discharge

  • Duration of hospital stay

    Hospital stay (mean 5 days)

  • Time of oxygen support

    Hospital stay (mean 5 days)

  • +3 more other outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Children in the intervention group will receive a protein-energy enriched milk (Infatrini®, or in the case of children on a partial or fully hydrolized milk Infatrini Peptisorb®). The volume of milk offered will be the same quantity as they usually drink at home (within the limits of 120-170 ml/kg/day). The intervention will be carried out during the first 7 days of hospitalisation, or until the day of discharge (if hospitalized for less than 7 days).

Dietary Supplement: Infatrini® or Infatrini Peptisorb®

Control group

NO INTERVENTION

Children in the control group will receive their regular milk. The volume of milk offered will be the same quantity as they usually drink at home (within the limits of 120-170 ml/kg/day).

Interventions

Intervention group

Eligibility Criteria

AgeUp to 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All children hospitalized at the paediatric wards of UZ Brussel with the diagnosis of moderate to severe bronchiolitis
  • Bronchiolitis will be defined as a constellation of clinical symptoms and signs that typically begin with rhinitis and cough, and may progress to tachypnea, wheezing, rales, use of accessory muscles and/or nasal flaring

You may not qualify if:

  • Children admitted to the paediatric intensive care unit
  • Children in whom it is unsafe to place a nasogastric tube (e.g. severe mucositis, platelet count \<50.000/µl)
  • Children unwilling or unable to participate
  • Children that are breast fed
  • Children over the age of 12 months
  • Children with an underlying malabsorption disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Brussel

Jette, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Bronchiolitis

Condition Hierarchy (Ancestors)

BronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Study Officials

  • Yvan Vandenplas, MD, PhD

    UZBrussel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Koen Huysentruyt, MD

CONTACT

Klaar Vergaelen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

December 5, 2014

First Posted

December 12, 2014

Study Start

December 1, 2014

Primary Completion

March 1, 2016

Study Completion

April 1, 2016

Last Updated

June 16, 2015

Record last verified: 2015-06

Locations